Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Augusto Ochoa
Lsu Health Sciences Center, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
LSU Health Sciences Center
Other : Patent Application
Per LSUHSC-NO's Individual and Institutional Conflicts of Interest in Sponsored Projects policy, investigators must disclose patents as well as patent applications based on the work or ideas of the investigator. Drs. Ochoa and Foster have applied for a patent (US Patent Application #13/828,669 and International Application #PCT/US13/31623) on March 15, 2013. The patent is currently pending prosecution. The patent application is titled "Methods for treatment of ocular diseases." The patent application describes methods of treatment of ocular diseases that simultaneously treat inflammation and neovascularization of the eyes while promoting healing. Preliminary data within the patent application was included with the grant award application. Augusto Ochoa is the PI on the NIH-NIAID award titled "Metabolic Approaches to Treat Severe Viral and Inflammatory Diseases." Current effective anti-viral drugs do not prevent inflammatory complications, including blindness, encephalitis, and acute respiratory distress syndrome, which are associated with severe viral diseases. Dr. Ochoa will study whether metabolic changes in tissue microenvironments can inhibit viral replication, modulate inflammatory and angiogenic responses, and promote tissue healing, while allowing the development of a protective immune response.
Metabolic approaches to treat severe viral and inflammatory diseases
Severe viral diseases such as infections of the cornea by Herpes virus and adenovirus, encephalitis by West Nile virus, and pandemic influenza cause serious complications and frequently result in permanent disabilities. The disease is caused by the combined effect of the viral infection and an overactive immune response and current anti-viral drugs do not always prevent the damaging effects of the disease. Therefore, it is important to find a treatment that can inhibit the growth of the virus and control inflammation while allowin for the development of protective and long lasting immunity; simple and achievable metabolic changes can provide both effects and promote healing of the tissues.
Filed on November 21, 2013.
Tell us what you know about Augusto Ochoa's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.